Development of AML with t(8;21)(q22;q22) and RUNX1-RUNX1T1 fusion following Philadelphia-negative clonal evolution during treatment of CML with Imatinib
Philippe Schafhausen, Judith Dierlamm, Carsten Bokemeyer, Tim H. Bruemmendorf, Ulrike Bacher, Axel R. Zander, Susanne Schnittger, Andreas HochhausVolume:
189
Year:
2009
Language:
english
Pages:
5
DOI:
10.1016/j.cancergencyto.2008.09.016
File:
PDF, 217 KB
english, 2009